{"transactions":[{"id":696334,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-08-05T20:15:51.000Z","date":"2026-08-03","kind":"other","planned":false,"acquired":true,"shares":22119,"price":48.43,"value":1071223.17,"ownership":{"direct":false,"nature":"By 401(k)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock."}],"balance_after":22119,"source":{"system":"sec-edgar","filing":"0001225208-26-006950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826006950/doc4.xml","form_type":"4"}},{"id":696333,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-08-05T20:15:51.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":186240,"price":48.3323,"value":9001407.552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $47.87 to $48.47, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":1590024,"source":{"system":"sec-edgar","filing":"0001225208-26-006950","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826006950/doc4.xml","form_type":"4"}},{"id":757920,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-06-01T20:18:00.000Z","date":"2026-05-28","kind":"gift","planned":false,"acquired":false,"shares":386755,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to The Michael F. Mahoney Term Irrevocable Trust - 2026, which is administered by an independent trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-26-005670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826005670/doc4.xml","form_type":"4"}},{"id":309650,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2026-05-15T21:23:59.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":1737.0046,"price":97.15,"value":168749.99689,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person."}],"balance_after":6428.8174,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1737.0046},"source":{"system":"sec-edgar","filing":"0000064803-26-000078","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000078/form4.xml","form_type":"4"}},{"id":898674,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":false,"shares":16265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":16265},"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898673,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":16524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":16524,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":16524},"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898672,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":8832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":26498,"derivative":{"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8832},"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898671,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7865,"price":74.73,"value":587751.45,"ownership":{"direct":true},"balance_after":1576860,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898670,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-16","kind":"exercise","planned":false,"acquired":true,"shares":16265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1584725,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898669,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7990,"price":74.73,"value":597092.7,"ownership":{"direct":true},"balance_after":1568460,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898668,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":16524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1576450,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898667,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":132099,"price":74.73,"value":9871758.27,"ownership":{"direct":true},"balance_after":1559926,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898666,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":8832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1692025,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898665,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":132190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 14, 2023, the reporting person was awarded a target number of performance share units under the Company's 2023 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2025 and subject to the completion of the concurrent three-year individual service period. On February 13, 2026, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."}],"balance_after":1683193,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":898664,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T22:58:51.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":132190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 14, 2023, the reporting person was awarded a target number of performance share units under the Company's 2023 Organic Net Sales Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's organic net sales performance measured against its financial plan over the three-year performance cycle comprising the three-year period ended December 31, 2025 and subject to the completion of the concurrent three-year individual service period. On February 13, 2026, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."}],"balance_after":1551003,"source":{"system":"sec-edgar","filing":"0001225208-26-002135","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002135/doc4.xml","form_type":"4"}},{"id":903207,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-18T00:06:51.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":131329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."}],"balance_after":131329,"derivative":{"exercise_price":74.12,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":131329},"source":{"system":"sec-edgar","filing":"0001225208-26-002016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002016/doc4.xml","form_type":"4"}},{"id":903206,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T00:06:51.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":55652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant."}],"balance_after":55652,"derivative":{"expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":55652},"source":{"system":"sec-edgar","filing":"0001225208-26-002016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002016/doc4.xml","form_type":"4"}},{"id":903205,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-02-18T00:06:51.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":false,"shares":13704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":27408,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":13704},"source":{"system":"sec-edgar","filing":"0001225208-26-002016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002016/doc4.xml","form_type":"4"}},{"id":903204,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T00:06:51.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":6626,"price":74.12,"value":491119.12,"ownership":{"direct":true},"balance_after":1418813,"source":{"system":"sec-edgar","filing":"0001225208-26-002016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002016/doc4.xml","form_type":"4"}},{"id":903203,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-18T00:06:51.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":true,"shares":13704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1425439,"source":{"system":"sec-edgar","filing":"0001225208-26-002016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826002016/doc4.xml","form_type":"4"}},{"id":923073,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:12:21.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":49407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":98814,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":49407},"source":{"system":"sec-edgar","filing":"0001225208-26-001156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826001156/doc4.xml","form_type":"4"}},{"id":923072,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:12:21.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":46347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant."}],"balance_after":231739,"derivative":{"exercise_price":27.09,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":46347},"source":{"system":"sec-edgar","filing":"0001225208-26-001156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826001156/doc4.xml","form_type":"4"}},{"id":923071,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-03T21:12:21.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":159701,"price":93.4905,"value":14930526.3405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.985, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1411735,"source":{"system":"sec-edgar","filing":"0001225208-26-001156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826001156/doc4.xml","form_type":"4"}},{"id":923070,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-03T21:12:21.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":94.0567,"value":112868.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.13, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1571436,"source":{"system":"sec-edgar","filing":"0001225208-26-001156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826001156/doc4.xml","form_type":"4"}},{"id":923069,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-03T21:12:21.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":46347,"price":27.09,"value":1255540.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025."}],"balance_after":1572636,"source":{"system":"sec-edgar","filing":"0001225208-26-001156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826001156/doc4.xml","form_type":"4"}},{"id":923068,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2026-02-03T21:12:21.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":49407,"price":24.55,"value":1212941.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 29, 2025."}],"balance_after":1526289,"source":{"system":"sec-edgar","filing":"0001225208-26-001156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520826001156/doc4.xml","form_type":"4"}},{"id":316816,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2025-11-21T22:43:31.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":2021.9621,"price":76.04,"value":153749.998084,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person."}],"balance_after":4613.3964,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2021.9621},"source":{"system":"sec-edgar","filing":"0000064803-25-000063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000063/form4.xml","form_type":"4"}},{"id":1010957,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-10-31T20:12:17.000Z","date":"2025-10-30","kind":"gift","planned":false,"acquired":false,"shares":149992,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to The Michael F. Mahoney Term Irrevocable Trust - 2025, which is administered by an independent trustee."}],"balance_after":213679,"source":{"system":"sec-edgar","filing":"0001225208-25-008843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825008843/doc4.xml","form_type":"4"}},{"id":1010956,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-10-31T20:12:17.000Z","date":"2025-10-29","kind":"gift","planned":false,"acquired":true,"shares":73996,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2024, which is administered by an independent trustee."}],"balance_after":363671,"source":{"system":"sec-edgar","filing":"0001225208-25-008843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825008843/doc4.xml","form_type":"4"}},{"id":1010955,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-10-31T20:12:17.000Z","date":"2025-10-29","kind":"gift","planned":false,"acquired":true,"shares":88197,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2023, which is administered by an independent trustee."}],"balance_after":289675,"source":{"system":"sec-edgar","filing":"0001225208-25-008843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825008843/doc4.xml","form_type":"4"}},{"id":1126371,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T20:47:04.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":false,"shares":49407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":148221,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":49407},"source":{"system":"sec-edgar","filing":"0001225208-25-005681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825005681/doc4.xml","form_type":"4"}},{"id":1126370,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T20:47:04.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":false,"shares":56212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":56212},"source":{"system":"sec-edgar","filing":"0001225208-25-005681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825005681/doc4.xml","form_type":"4"}},{"id":1126369,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:47:04.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":89921,"price":103.3902,"value":9296950.1742,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.83 to $103.825 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1476882,"source":{"system":"sec-edgar","filing":"0001225208-25-005681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825005681/doc4.xml","form_type":"4"}},{"id":1126368,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:47:04.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":74522,"price":104.0523,"value":7754185.5006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.83 to $104.755, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1566803,"source":{"system":"sec-edgar","filing":"0001225208-25-005681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825005681/doc4.xml","form_type":"4"}},{"id":1126367,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:47:04.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":true,"shares":49407,"price":24.55,"value":1212941.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."}],"balance_after":1641325,"source":{"system":"sec-edgar","filing":"0001225208-25-005681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825005681/doc4.xml","form_type":"4"}},{"id":1126366,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-06-03T20:47:04.000Z","date":"2025-06-02","kind":"exercise","planned":true,"acquired":true,"shares":56212,"price":17.26,"value":970219.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."}],"balance_after":1591918,"source":{"system":"sec-edgar","filing":"0001225208-25-005681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825005681/doc4.xml","form_type":"4"}},{"id":322107,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Deferred Stock Units","published_at":"2025-05-19T21:46:21.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":2542.5831,"price":60.47,"value":153750.000057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Deferred Stock Compensation payable pursuant to Insider's election"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Deferred Stock Compensation payable pursuant to Insider's election"}],"balance_after":2542.5831,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2542.5831},"source":{"system":"sec-edgar","filing":"0001127602-25-014956","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760225014956/form4.xml","form_type":"4"}},{"id":322106,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-19T21:46:21.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":144,"price":60.47,"value":8707.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."}],"balance_after":6345,"source":{"system":"sec-edgar","filing":"0001127602-25-014956","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760225014956/form4.xml","form_type":"4"}},{"id":1160110,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T21:16:27.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":false,"shares":49407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":197628,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":49407},"source":{"system":"sec-edgar","filing":"0001225208-25-004717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004717/doc4.xml","form_type":"4"}},{"id":1160109,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T21:16:27.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":false,"shares":56212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":56212,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":56212},"source":{"system":"sec-edgar","filing":"0001225208-25-004717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004717/doc4.xml","form_type":"4"}},{"id":1160108,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-05-05T21:16:27.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":91282,"price":102.126,"value":9322265.532,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.61 to $102.60, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1535706,"source":{"system":"sec-edgar","filing":"0001225208-25-004717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004717/doc4.xml","form_type":"4"}},{"id":1160107,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-05-05T21:16:27.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":73161,"price":102.9197,"value":7529708.1717,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.64 to $103.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1626988,"source":{"system":"sec-edgar","filing":"0001225208-25-004717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004717/doc4.xml","form_type":"4"}},{"id":1160106,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-05-05T21:16:27.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":true,"shares":49407,"price":24.55,"value":1212941.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."}],"balance_after":1700149,"source":{"system":"sec-edgar","filing":"0001225208-25-004717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004717/doc4.xml","form_type":"4"}},{"id":1160105,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-05-05T21:16:27.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":true,"shares":56212,"price":17.26,"value":970219.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."}],"balance_after":1650742,"source":{"system":"sec-edgar","filing":"0001225208-25-004717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825004717/doc4.xml","form_type":"4"}},{"id":1185012,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T20:12:44.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":false,"shares":49407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":247035,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":49407},"source":{"system":"sec-edgar","filing":"0001225208-25-003866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825003866/doc4.xml","form_type":"4"}},{"id":1185011,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T20:12:44.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":false,"shares":56211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":112424,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":56211},"source":{"system":"sec-edgar","filing":"0001225208-25-003866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825003866/doc4.xml","form_type":"4"}},{"id":1185010,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-04-02T20:12:44.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":164442,"price":100.0053,"value":16445071.5426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $99.50 to $100.40, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1594530,"source":{"system":"sec-edgar","filing":"0001225208-25-003866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825003866/doc4.xml","form_type":"4"}},{"id":1185009,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-04-02T20:12:44.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":true,"shares":49407,"price":24.55,"value":1212941.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."}],"balance_after":1758972,"source":{"system":"sec-edgar","filing":"0001225208-25-003866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825003866/doc4.xml","form_type":"4"}},{"id":1185008,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-04-02T20:12:44.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":true,"shares":56211,"price":17.26,"value":970201.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 15, 2024."}],"balance_after":1709565,"source":{"system":"sec-edgar","filing":"0001225208-25-003866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825003866/doc4.xml","form_type":"4"}},{"id":325722,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Common Stock (By Trust)","published_at":"2025-02-19T17:35:35.000Z","date":"2025-02-18","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":66.7,"value":2001000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of shares held in trusts for the benefit of the reporting person or the reporting person and his spouse."}],"balance_after":39356,"source":{"system":"sec-edgar","filing":"0001127602-25-005398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760225005398/form4.xml","form_type":"4"}},{"id":1265176,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":false,"shares":18334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":18334},"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265175,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-16","kind":"exercise","planned":false,"acquired":false,"shares":16265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":16265,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":16265},"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265174,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":16524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant."}],"balance_after":33048,"derivative":{"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":16524},"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265173,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":90915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":90915,"derivative":{"exercise_price":106.14,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":90915},"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265172,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":35330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 13, 2026, the first anniversary of the date of grant."}],"balance_after":35330,"derivative":{"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":35330},"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265171,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":8865,"price":106.11,"value":940665.15,"ownership":{"direct":true},"balance_after":1653354,"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265170,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-17","kind":"exercise","planned":false,"acquired":true,"shares":18334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1662219,"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265169,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7865,"price":106.11,"value":834555.15,"ownership":{"direct":true},"balance_after":1643885,"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265168,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-16","kind":"exercise","planned":false,"acquired":true,"shares":16265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1651750,"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265167,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":7990,"price":106.11,"value":847818.9,"ownership":{"direct":true},"balance_after":1635485,"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1265166,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-18T22:52:08.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":16524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1643475,"source":{"system":"sec-edgar","filing":"0001225208-25-001871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001871/doc4.xml","form_type":"4"}},{"id":1268463,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-14T22:29:54.000Z","date":"2025-02-12","kind":"exercise","planned":false,"acquired":false,"shares":13704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant."}],"balance_after":41112,"derivative":{"expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":13704},"source":{"system":"sec-edgar","filing":"0001225208-25-001792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001792/doc4.xml","form_type":"4"}},{"id":1268462,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-14T22:29:54.000Z","date":"2025-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":6626,"price":105.77,"value":700832.02,"ownership":{"direct":true},"balance_after":1626951,"source":{"system":"sec-edgar","filing":"0001225208-25-001792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001792/doc4.xml","form_type":"4"}},{"id":1268461,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-14T22:29:54.000Z","date":"2025-02-12","kind":"exercise","planned":false,"acquired":true,"shares":13704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1633577,"source":{"system":"sec-edgar","filing":"0001225208-25-001792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001792/doc4.xml","form_type":"4"}},{"id":1270352,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-13T21:32:42.000Z","date":"2025-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":62915,"price":105.98,"value":6667731.7,"ownership":{"direct":true},"balance_after":1619873,"source":{"system":"sec-edgar","filing":"0001225208-25-001684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001684/doc4.xml","form_type":"4"}},{"id":1270351,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-02-13T21:32:42.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":130118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2024 and subject to the completion of the concurrent three-year individual service period. On February 11, 2025, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."}],"balance_after":1682788,"source":{"system":"sec-edgar","filing":"0001225208-25-001684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825001684/doc4.xml","form_type":"4"}},{"id":1317036,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Performance Share Units","published_at":"2025-01-03T21:32:59.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":57121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance shares unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-12-31","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":57121},"source":{"system":"sec-edgar","filing":"0001225208-25-000205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000205/doc4.xml","form_type":"4"}},{"id":1317035,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-01-03T21:32:59.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":25656,"price":89.32,"value":2291593.92,"ownership":{"direct":true},"balance_after":1552670,"source":{"system":"sec-edgar","filing":"0001225208-25-000205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000205/doc4.xml","form_type":"4"}},{"id":1317034,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2025-01-03T21:32:59.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":57121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 10, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2022 adjusted free cash flow measured against its 2022 financial plan over the one-year performance period ending December 31, 2022 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 14, 2023, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2024."}],"balance_after":1578326,"source":{"system":"sec-edgar","filing":"0001225208-25-000205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520825000205/doc4.xml","form_type":"4"}},{"id":1350092,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-11-27T21:29:02.000Z","date":"2024-11-26","kind":"gift","planned":false,"acquired":false,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":201478,"source":{"system":"sec-edgar","filing":"0001225208-24-010259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824010259/doc4.xml","form_type":"4"}},{"id":329011,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-25T22:43:57.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":2200,"price":57.1,"value":125620.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."}],"balance_after":6201,"source":{"system":"sec-edgar","filing":"0001127602-24-028001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760224028001/form4.xml","form_type":"4"}},{"id":1373425,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-07T21:45:08.000Z","date":"2024-11-05","kind":"exercise","planned":true,"acquired":false,"shares":55676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":16.31,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":55676},"source":{"system":"sec-edgar","filing":"0001225208-24-009728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009728/doc4.xml","form_type":"4"}},{"id":1373424,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-07T21:45:08.000Z","date":"2024-11-05","kind":"exercise","planned":true,"acquired":false,"shares":56211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":168635,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":56211},"source":{"system":"sec-edgar","filing":"0001225208-24-009728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009728/doc4.xml","form_type":"4"}},{"id":1373423,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-11-07T21:45:08.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":160182,"price":84.7395,"value":13573742.589,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.145 to $85.12, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1521205,"source":{"system":"sec-edgar","filing":"0001225208-24-009728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009728/doc4.xml","form_type":"4"}},{"id":1373422,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-11-07T21:45:08.000Z","date":"2024-11-05","kind":"sale","planned":true,"acquired":false,"shares":2596,"price":85.1727,"value":221108.3292,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $85.14 to $85.20, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1681387,"source":{"system":"sec-edgar","filing":"0001225208-24-009728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009728/doc4.xml","form_type":"4"}},{"id":1373421,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-11-07T21:45:08.000Z","date":"2024-11-05","kind":"exercise","planned":true,"acquired":true,"shares":55676,"price":16.31,"value":908075.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."}],"balance_after":1683983,"source":{"system":"sec-edgar","filing":"0001225208-24-009728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009728/doc4.xml","form_type":"4"}},{"id":1373420,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-11-07T21:45:08.000Z","date":"2024-11-05","kind":"exercise","planned":true,"acquired":true,"shares":56211,"price":17.26,"value":970201.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."}],"balance_after":1628307,"source":{"system":"sec-edgar","filing":"0001225208-24-009728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009728/doc4.xml","form_type":"4"}},{"id":1389659,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-08T21:48:21.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":false,"shares":55675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":55676,"derivative":{"exercise_price":16.31,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":55675},"source":{"system":"sec-edgar","filing":"0001225208-24-009234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/doc4.xml","form_type":"4"}},{"id":1389658,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-08T21:48:21.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":false,"shares":56211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":224846,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":56211},"source":{"system":"sec-edgar","filing":"0001225208-24-009234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/doc4.xml","form_type":"4"}},{"id":1389657,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-10-08T21:48:21.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":82085,"price":84.9416,"value":6972431.236,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $84.75 to $85.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1572096,"source":{"system":"sec-edgar","filing":"0001225208-24-009234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/doc4.xml","form_type":"4"}},{"id":1389656,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-10-08T21:48:21.000Z","date":"2024-10-07","kind":"sale","planned":true,"acquired":false,"shares":80692,"price":84.3127,"value":6803360.3884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $83.75 to $84.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1654181,"source":{"system":"sec-edgar","filing":"0001225208-24-009234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/doc4.xml","form_type":"4"}},{"id":1389655,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-10-08T21:48:21.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":true,"shares":55675,"price":16.31,"value":908059.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."}],"balance_after":1734873,"source":{"system":"sec-edgar","filing":"0001225208-24-009234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/doc4.xml","form_type":"4"}},{"id":1389654,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-10-08T21:48:21.000Z","date":"2024-10-07","kind":"exercise","planned":true,"acquired":true,"shares":56211,"price":17.26,"value":970201.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."}],"balance_after":1679198,"source":{"system":"sec-edgar","filing":"0001225208-24-009234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824009234/doc4.xml","form_type":"4"}},{"id":1413150,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T20:12:12.000Z","date":"2024-09-05","kind":"exercise","planned":true,"acquired":false,"shares":55675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":111351,"derivative":{"exercise_price":16.31,"expiration_date":"2025-02-23","underlying":"Common Stock","underlying_shares":55675},"source":{"system":"sec-edgar","filing":"0001225208-24-008529","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008529/doc4.xml","form_type":"4"}},{"id":1413149,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T20:12:12.000Z","date":"2024-09-05","kind":"exercise","planned":true,"acquired":false,"shares":56211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":281057,"derivative":{"exercise_price":17.26,"expiration_date":"2026-02-22","underlying":"Common Stock","underlying_shares":56211},"source":{"system":"sec-edgar","filing":"0001225208-24-008529","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008529/doc4.xml","form_type":"4"}},{"id":1413148,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-09-06T20:12:12.000Z","date":"2024-09-05","kind":"sale","planned":true,"acquired":false,"shares":162777,"price":81.1696,"value":13212543.9792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $80.52 to $81.80, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1622987,"source":{"system":"sec-edgar","filing":"0001225208-24-008529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008529/doc4.xml","form_type":"4"}},{"id":1413147,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-09-06T20:12:12.000Z","date":"2024-09-05","kind":"exercise","planned":true,"acquired":true,"shares":55675,"price":16.31,"value":908059.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."}],"balance_after":1785764,"source":{"system":"sec-edgar","filing":"0001225208-24-008529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008529/doc4.xml","form_type":"4"}},{"id":1413146,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-09-06T20:12:12.000Z","date":"2024-09-05","kind":"exercise","planned":true,"acquired":true,"shares":56211,"price":17.26,"value":970201.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024."}],"balance_after":1730089,"source":{"system":"sec-edgar","filing":"0001225208-24-008529","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008529/doc4.xml","form_type":"4"}},{"id":1418248,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-09-03T21:28:20.000Z","date":"2024-08-30","kind":"gift","planned":false,"acquired":false,"shares":176245,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction involved a gift of securities by the reporting person to The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2024, which is administered by an independent trustee."}],"balance_after":209278,"source":{"system":"sec-edgar","filing":"0001225208-24-008332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008332/doc4.xml","form_type":"4"}},{"id":1418247,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-09-03T21:28:20.000Z","date":"2024-08-30","kind":"gift","planned":false,"acquired":true,"shares":95041,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction involved a gift of securities by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2022, which is administered by an independent trustee."}],"balance_after":385523,"source":{"system":"sec-edgar","filing":"0001225208-24-008332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008332/doc4.xml","form_type":"4"}},{"id":1418246,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-09-03T21:28:20.000Z","date":"2024-08-30","kind":"gift","planned":false,"acquired":true,"shares":114237,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2023, which is administered by an independent trustee."}],"balance_after":290482,"source":{"system":"sec-edgar","filing":"0001225208-24-008332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824008332/doc4.xml","form_type":"4"}},{"id":333629,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-17T21:40:41.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2184,"price":57.52,"value":125623.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan."}],"balance_after":4001,"source":{"system":"sec-edgar","filing":"0001127602-24-015902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760224015902/form4.xml","form_type":"4"}},{"id":334189,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true}}],"security":"Common Stock (By Trust)","published_at":"2024-05-02T20:30:49.000Z","date":"2024-05-02","kind":"purchase","planned":false,"acquired":true,"shares":9181,"price":54.4923,"value":500293.8063,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of shares held in trusts for the benefit of the reporting person or the reporting person and his spouse."}],"balance_after":9356,"source":{"system":"sec-edgar","filing":"0001127602-24-013995","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760224013995/form4.xml","form_type":"4"}},{"id":1635683,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Deferred Stock Units","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":false,"shares":16307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":16307},"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}},{"id":1635682,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-17","kind":"exercise","planned":false,"acquired":false,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant."}],"balance_after":18334,"derivative":{"expiration_date":"2025-02-17","underlying":"Common Stock","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}},{"id":1635681,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":16265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant."}],"balance_after":32530,"derivative":{"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":16265},"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}},{"id":1635680,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":7233,"price":65.82,"value":476076.06,"ownership":{"direct":true},"balance_after":1673878,"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}},{"id":1635679,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":true,"shares":16307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock."}],"balance_after":1681111,"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}},{"id":1635678,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":8131,"price":65.82,"value":535182.42,"ownership":{"direct":true},"balance_after":1664804,"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}},{"id":1635677,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":14655,"kind":"person","name":"Mahoney Michael F","position":1,"cik":"0001533022","reported_name":"Mahoney Michael F","relationship":{"director":true,"officer":true,"officer_title":"Chairman, President & CEO"}}],"security":"Common Stock","published_at":"2024-02-21T02:03:45.000Z","date":"2024-02-17","kind":"exercise","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."}],"balance_after":1672935,"source":{"system":"sec-edgar","filing":"0001225208-24-002576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520824002576/doc4.xml","form_type":"4"}}],"next_cursor":"2024-02-21T02:03:45.000000Z,1635677"}